Tremor: Clinical Trials

10 trials for Tremor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 recruiting, 1 terminated, 1 unknown. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 5, Recruiting 3, Terminated 1, Unknown 1

Follow Tremor: new trials by email Literature Review of Tremor trials Research Report on Tremor

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
Conversion to extended-release tacrolimus, Maintenance of immediate-release tacrolimus - Kidney Transplant Recipients, Old Age
Phase 4RecruitingMassachusetts General Hospital922026-03-172026-05-28
Istradefylline Effect Protocol on Parkinson's Disease Tremor
Istradefylline Pill - Parkinson Disease, Tremor
Phase 4CompletedGeorgetown University272023-01-202025-03-13
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release Oral Tablet - Liver Transplantation, Immunosuppression
Phase 4RecruitingUniversity of British Columbia1242023-01-092024-01-02
Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients?
IV Ondansetron 4mg, Higher OT temperature range, Placebo - Temperature Change, Body, Chills
Phase 4UnknownDr Lim Siu Min6282020-10-132021-10-14
A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor
Abobotulinum toxin A, Placebo - Tremor, Limb
Phase 4RecruitingDavid M. Simpson252018-12-042021-02-25
SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)
Lithium sulphate prolonged-release 660 mg, Lithium carbonate immediate-release 150 mg and 300 mg - Bipolar Disorder
Phase 4TerminatedAziende Chimiche Riunite Angelini Francesco S.p.A852017-03-282020-01-10
Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response
Ethanol, Propranolol - Essential Tremor, Tremor
Phase 4CompletedUniversity of California, San Diego562013-12-012020-12-02
Pregabalin (Lyrica) for the Treatment of Essential Tremor
Pregabalin, Placebo - Essential Tremor
Phase 4CompletedUniversity of South Florida292007-12-012012-06-18
Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
Carbidopa/levodopa/entacapone - Parkinson's Disease With End of Dose Wearing Off
Phase 4CompletedNovartis Pharmaceuticals3592005-01-012017-03-30
Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia
Botulinum toxin, type B - Focal Dystonia
Phase 4CompletedColumbia University162003-04-012014-05-09

Narrower conditions

Essential Tremor (2)  ·  Parkinson Disease (2)  ·  Bipolar Disorder (1)  ·  Body Temperature Changes (1)  ·  Chills (1)  ·  Dystonic Disorders (1)  ·  Muscle Hypotonia (1)  ·  Neurotoxicity Syndromes (1)  ·  Postoperative Nausea and Vomiting (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Broader conditions

Dyskinesias (10)  ·  Nervous System Diseases (10)  ·  Neurologic Manifestations (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Signs and Symptoms (10)  ·  Central Nervous System Diseases (5)  ·  Movement Disorders (5)  ·  Basal Ganglia Diseases (2)  ·  Brain Diseases (2)  ·  Mental Disorders (2)  ·  Neurodegenerative Diseases (2)  ·  Parkinsonian Disorders (2)  ·  Synucleinopathies (2)  ·  Bipolar and Related Disorders (1)  ·  Chemically-Induced Disorders (1)

Interventions

Tacrolimus (2)  ·  Ethanol (1)  ·  Ondansetron (1)  ·  Pregabalin (1)  ·  Propranolol (1)  ·  Stalevo (1)  ·  abobotulinumtoxinA (1)  ·  istradefylline (1)  ·  rimabotulinumtoxinB (1)

Sponsors

Aziende Chimiche Riunite Angelini Francesco S.p.A (1)  ·  Columbia University (1)  ·  David M. Simpson (1)  ·  Dr Lim Siu Min (1)  ·  Georgetown University (1)  ·  Massachusetts General Hospital (1)  ·  Novartis Pharmaceuticals (1)  ·  University of British Columbia (1)  ·  University of California, San Diego (1)  ·  University of South Florida (1)

Countries

United States (7)  ·  Canada (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Puerto Rico (1)

Top investigators

David M Simpson, MD (1)  ·  Fatta B Nahab, MD (1)  ·  Fernando Pagan (1)  ·  Jo-Ann Ford, RN (1)  ·  Leonardo V. Riella, MD, PhD (1)  ·  Seth Pullman, MD (1)  ·  Theresa A Zesiewicz, MD (1)  ·  Trana Hussaini, Pharm D (1)

Results publications

PMID 11812709, PMID 12768180, PMID 18433676, PMID 27622717, PMID 31111094

NIH funding

2016 (1), R01NS073683 (1)